BIONIK Laboratories Corp. Annual report pursuant to Section 13 and 15(d)

Share-Based Compensation (Tables)

12 Months Ended

Mar. 31, 2023


						Weighted-
				Weighted-		Average
				Average		Remaining
	Number of	Exercise Price		Exercise		Contractual
	Options	Range		Price		Life
Vested	570,068	$	1.21 – 157.50	$	7.86	4.91 years
Unvested	207,197		2.10 – 24.15		2.54	6.51 years
Outstanding, March 31, 2022	777,265	$	1.21 – 183.00	$	6.46	5.34 years
Issued	244,000		0.30		0.30
Exercised	—		—		—
Forfeited	(93,247)		2.10 - 158.00		12.15
Outstanding, March 31, 2023	928,018	$	0.30 - 157.50	$	4.25	4.84 years
Vested	582,102		1.21 – 157.50		6.29	4.01 years
Unvested	345,916		0.30 – 2.10		0.83	6.24 years
Vested or expected to vest, March 31, 2023	928,018		0.30 – 157.50		4.25	4.84 years
Exercisable, March 31, 2023	582,102	$	1.21 – 157.50	$	6.29	4.01 years